Person: Rory Nealon

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

business

Management change at Trinity Biotech

TRINITY Biotech, the Bray-based maker of tests for conditions such as HIV, has announced a shake-up of its senior management.

business

Trinity Biotech revenue up 16.4% to €19.7m

business

Trinity Biotech announce revenue increase

business

Trinity Biotech directors buy 4.5m company shares

business

Trinity profits up almost a quarter in Q3

business

Trinity revenues up a fifth in Q2

Trinity shares drop 10% as Q1 profits fall

TRINITY BIOTECH shares slumped 10% yesterday after the Wicklow-based developer of clinical tests saw first-quarter pre-tax profits fall to $748,000 (€634,000), 60% less than the same period last year.

Thu, 29 Apr, 2004

Trinity Biotech revenues climb 6% in Q1

Bray-based diagnostic manufacturer Trinity Biotech saw revenues up 6% to $16.4m (€13.84m) for the first quarter of 2004.

Wed, 28 Apr, 2004

Trinity Biotech profile

CLINICAL healthcare company Trinity Biotech reports first quarter results on Wednesday. The Bray-based company saw pre-tax profits rise to $8 million (€6.25m) last year, up from $5.7min 2002.

Mon, 26 Apr, 2004

Trinity Biotech profits increase

TRINITY BIOTECH, the Wicklow-based developer of tests for infectious and sexually transmitted diseases, saw pre-tax profits rise to $8 million (€6.25 million) last year, up from $5.7 million in 2002.

Wed, 18 Feb, 2004